Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
Open accessPublished version of a preprint
Abstract
Peritoneal metastases are the leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC). Accumulating evidence suggests that mesothelial cells are an important component of the metastatic microenvironment in HGSOC. However, the mechanisms by which mesothelial cells promote metastasis are unclear. Here, we report that the HGSOC tumor-mesothelial niche was hypoxic, and hypoxic signaling enhanced collagen I deposition by mesothelial cells. Specifically, hypoxic signaling increased expression of lysyl oxidase (LOX) in mesothelial and ovarian cancer cells to promote collagen crosslinking and tumor cell invasion. The mesothelial niche was enriched with fibrillar collagen in human and murine omental metastases. Pharmacologic inhibition of LOX reduced tumor burden and collagen remodeling in murine omental metastases. These findings highlight an important role for hypoxia and mesothelial cells in the modification of the extracellular matrix and tumor invasion in HGSOC. Significance: This study identifies HIF/LOX signaling as a potential therapeutic target to inhibit collagen remodeling and tumor progression in HGSOC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Collagen interaction with fibronectin, laminin, hyaluronic acid, and MMPs influences cancer cell activity.
“Moreover, collagen interaction with other ECM molecules including fibronectin, laminin, hyaluronic acid, and MMPs influences cancer cell activity [127].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [127]
The Discussion (page unavailable) says collagen deposition and remodeling can promote tumor proliferation and invasion, supporting the broad point that collagen influences cancer-cell activity. The paper does not say that interactions between collagen and fibronectin, laminin, hyaluronic acid, or MMPs produce those effects; its results instead examine collagen remodeling involving LOX. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309 · see citing works
RetractedGilkes, D. M., Bajpai, S. K., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 472 · see citing works
RetractedHypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · see citing works
Junqueira, L. C. U., Bignolas, G., & Brentani, H. (1979) · The Histochemical Journal · doi:10.1007/bf01002772 · Cited by 2,570 · see citing works
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,083 · see citing works
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,791 · see citing works
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520 · see citing works
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376 · see citing works
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D. L., Böhm, S., Ahmed, A. A., Aspuria, P.-J. P., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S. P., Bookman, M. A., et al. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4019 · Cited by 1,365 · see citing works
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works
Self-citationCollagens, modifying enzymes and their mutations in humans, flies and worms
Myllyharju, J. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.11.004 · Cited by 1,179 · see citing works
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652 · see citing works
Chi, J., Wang, Z., Nuyten, D. S. A., Rodriguez, E. H., Schaner, M. E., Salim, A., Wang, Y., Kristensen, G. B., Helland, Å., Børresen‐Dale, A., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030047 · Cited by 615 · see citing works
The rationale for targeting the LOX family in cancer
Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3319 · Cited by 611 · see citing works
Development of a Syngeneic Mouse Model for Events Related to Ovarian Cancer
Roby, K. F., Taylor, C. C., Sweetwood, J. P., Cheng, Y., Pace, J. L., Tawfik, O., Persons, D. L., Smith, P. G., & Terranova, P. F. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.585 · Cited by 593 · see citing works
Mechanisms of transcoelomic metastasis in ovarian cancer
Tan, D. S. P., Agarwal, R., & Kaye, S. B. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70939-1 · Cited by 521 · see citing works
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461 · see citing works
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113483108 · Cited by 437 · see citing works
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 432 · see citing works
Oxygen: Modulator of metabolic zonation and disease of the liver
Jungermann, K., & Kietzmann, T. (2000) · Hepatology · doi:10.1002/hep.510310201 · Cited by 387 · see citing works
Cheon, D., Tong, Y., Sim, M., Dering, J., Berel, D., Cui, X., Lester, J., Beach, J. A., Tighiouart, M., Walts, A. E., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1256 · Cited by 374 · see citing works
Pearce, O. M. T., Delaine‐Smith, R. M., Maniati, E., Nichols, S., Wang, J., Böhm, S., Rajeeve, V., Ullah, D., Chakravarty, P., Jones, R. R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0284 · Cited by 339 · see citing works
Connell, N. D., & Rheinwald, J. G. (1983) · Cell · doi:10.1016/0092-8674(83)90155-1 · Cited by 326 · see citing works
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
Iwanicki, M. P., Davidowitz, R. A., Ng, M. R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., & Brugge, J. S. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0010 · Cited by 303 · see citing works
Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion
Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303 · see citing works
Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
Eisinger‐Mathason, T. S. K., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M. S., Karakasheva, T. A., Mucaj, V., Shay, J. E. S., Stangenberg, L., Sadri, N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0118 · Cited by 280 · see citing works
Rankin, E. B., Wu, C., Khatri, R., Wilson, T. L. S., Andersen, R., Araldi, E., Rankin, A. L., Yuan, J., Kuo, C. J., Schipani, E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.051 · Cited by 278 · see citing works
Self-citationDirect regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Rankin, E. B., Fuh, K. C., Castellini, L., Viswanathan, K., Finger, E. C., Diep, A. N., LaGory, E. L., Kariolis, M. S., Chan, A., Lindgren, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404848111 · Cited by 269 · see citing works
Self-citationChaturvedi, P., Gilkes, D. M., Wong, C. C., Gupta, K., Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64993 · Cited by 244 · see citing works
Chaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, K., Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69244 · Cited by 181 · see citing works
Arteel, G. E., Thurman, R. G., & Raleigh, J. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530743.x · Cited by 178 · see citing works
Oxygen tension regulates the expression of a group of procollagen hydroxylases
Hofbauer, K., Gess, B., Lohaus, C., Meyer, H. E., Katschinski, D., & Kurtz, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03846.x · Cited by 165 · see citing works
Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
Davidowitz, R. A., Selfors, L. M., Iwanicki, M., Elias, K. M., Karst, A. M., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69815 · Cited by 132 · see citing works
Qin, J., Liu, Y., Lu, Y., Liu, M., Li, M., Li, J., & Wu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09244-8 · Cited by 121 · see citing works
Osada, R., Horiuchi, A., Kikuchi, N., Yoshida, J., Hayashi, A., Ota, M., Katsuyama, Y., Mellilo, G., & Konishi, I. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.02.010 · Cited by 120 · see citing works
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2 · Cited by 120 · see citing works
Ryner, L. C., Guan, Y., Firestein, R., Xiao, Y., Choi, Y., Rabe, C., Lu, S., Fuentes, E., Huw, L., Lackner, M. R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3111 · Cited by 107 · see citing works
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
Seo, E. J., Kim, D. K., Jang, I. H., Choi, E. J., Shin, S., Lee, S. I., Kwon, S., Kim, K., Suh, D., & Kim, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10954 · Cited by 99 · see citing works
Barberis, M. C. P., Faleri, M., Veronese, S. M., Casadio, C., & Viale, G. (1997) · Acta Cytologica · doi:10.1159/000333181 · Cited by 98 · see citing works
Bignotti, E., Tassi, R. A., Calza, S., Ravaggi, A., Bandiera, E., Rossi, E., Donzelli, C., Pasinetti, B., Pecorelli, S. L., & Santin, A. D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.10.874 · Cited by 96 · see citing works
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
Rupaimoole, R., Ivan, C., Yang, D., Gharpure, K. M., Wu, S. Y., Pecot, C. V., Previs, R. A., Nagaraja, A. S., Armaiz-Peña, G. N., McGuire, M. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.492 · Cited by 96 · see citing works
Engineering extracellular matrix structure in 3D multiphase tissues
Gillette, B. M., Rossen, N. S., Das, N., Leong, D., Wang, M., Dugar, A., & Sia, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.043 · Cited by 73 · see citing works
Self-citationExtracellular matrix genes as hypoxia-inducible targets
Myllyharju, J., & Schipani, E. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0841-7 · Cited by 72 · see citing works
Brodsky, A. S., Fischer, A. K., Miller, D., Vang, S., MacLaughlan, S. D., Wu, H.-T., Yu, J., Steinhoff, M. M., Collins, C. C., Smith, P. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094476 · Cited by 65 · see citing works
The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
Wilson, C. B., Qiu, L., Hong, Y., Karnik, T., Tadros, G., Mau, B., Ma, T., Mu, Y., New, J., Louie, R. J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.412 · Cited by 61 · see citing works
Self-citationTWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis
Grither, W. R., Divine, L. M., Meller, E. H., Wilke, D., Desai, R. A., Loza, A. J., Zhao, P., Lohrey, A. K., Longmore, G. D., & Fuh, K. C. (2018) · Oncogene · doi:10.1038/s41388-017-0043-9 · Cited by 60 · see citing works
Self-citationLoss of Fibroblast HIF-1α Accelerates Tumorigenesis
Kim, J., Evans, C. E., Weidemann, A., Takeda, N., Lee, Y. S., Stockmann, C., Branco‐Price, C., Brandberg, F., Leone, G. W., Ostrowski, M. C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0534 · Cited by 58 · see citing works
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Iwanicki, M., Chen, H., Iavarone, C., Zervantonakis, I. K., Muranen, T. E., Novak, M., Ince, T. A., Drapkin, R., & Brugge, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.86829 · Cited by 54 · see citing works
SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α
Ao, Q., Su, W., Guo, S., Cai, L., & Huang, L. (2015) · Scientific Reports · doi:10.1038/srep16396 · Cited by 49 · see citing works
Mikuła‐Pietrasik, J., Sosińska, P., Kucińska, M., Murias, M., Maksin, K., Malińska, A., Ziółkowska, A., PIOTROWSKA, H., Woźniak, A., & Książek, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.041 · Cited by 36 · see citing works
Peters, P., Schryver, E. M., Lengyel, E. R., & Kenny, H. A. (2015) · Journal of Visualized Experiments · doi:10.3791/53541 · Cited by 21 · see citing works
Detection of Hypoxia and HIF in Paraffin-Embedded Tumor Tissues
Li, F., Lee, K. E., & Simon, M. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7665-2_24 · Cited by 16 · see citing works
Abstract 3187: Ex vivo characterization of CTCs isolated using the FMSA device
Cheng, H., Gallant, J., Harouaka, R. A., Zheng, S., & El‐Deiry, W. S. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3187 · Cited by 6 · see citing works
Peters, P., Schryver, E. M., Lengyel, E. R., & Kenny, H. A. (2015) · Journal of Visualized Experiments · doi:10.3791/53541-v · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784 · see citing works
“Moreover, collagen interaction with other ECM molecules including fibronectin, laminin, hyaluronic acid, and MMPs influences cancer cell activity [127] .”
BackgroundYuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977 · see citing works
Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T. M., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 295 · see citing works
Lin, Z., Song, J., Gao, Y., Huang, S., Dou, R., Zhong, P., Huang, G., Han, L., Zheng, J., Zhang, X., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102312 · Cited by 240 · see citing works
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Schoutrop, E., Moyano‐Galceran, L., Lheureux, S., Mattsson, J., Lehti, K., Dahlstrand, H. M., & Magalhaes, I. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.027 · Cited by 176 · see citing works
Co-evolution of Matrisome and Adaptive Adhesion Dynamics Drives Ovarian Cancer Chemoresistance
Pietilä, E. A., Gonzalez-Molina, J., Moyano-Galceran, L., Jamalzadeh, S., Zhang, K., Lehtinen, L., Turunen, S. P., Martins, T. A., Gultekin, O., Lamminen, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24009-8 · Cited by 175 · see citing works
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 162 · see citing works
Qian, J., LeSavage, B. L., Hubka, K. M., Ma, C., Natarajan, S., Eggold, J. T., Xiao, Y., Fuh, K. C., Krishnan, V., Enejder, A. M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146186 · Cited by 132 · see citing works
Self-citationGlycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 129 · see citing works
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 125 · see citing works
Tumor microenvironment in ovarian cancer peritoneal metastasis
Mei, S., Chen, X., Wang, K., & Chen, Y. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02854-5 · Cited by 112 · see citing works
Targeting the immune microenvironment for ovarian cancer therapy
Blanc‐Durand, F., Xian, L. C. W., & Tan, D. S. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1328651 · Cited by 110 · see citing works
Krishnan, V., Tallapragada, S., Schaar, B. T., Kamat, K. D., Chanana, A. M., Zhang, Y., Patel, S. A., Parkash, V., Rinker-Schaeffer, C. W., Folkins, A. K., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01246-z · Cited by 99 · see citing works
Self-citationEvolving roles of lysyl oxidase family in tumorigenesis and cancer therapy
Ye, M., Song, Y., Pan, S., Chu, M., Wang, Z. P., & Zhu, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107633 · Cited by 89 · see citing works
Mechanical signatures in cancer metastasis
Agrawal, A., Javanmardi, Y., Watson, S. A., Serwinski, B., Djordjevic, B., Li, W., Aref, A. R., Jenkins, R. W., & Moeendarbary, E. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00007-x · Cited by 89 · see citing works
Zhang, Q., An, Z.-Y., Jiang, W. G., Jin, W., & He, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115390 · Cited by 79 · see citing works
Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
Amendola, P. G., Reuten, R., & Erler, J. T. (2019) · Cancers · doi:10.3390/cancers11050729 · Cited by 76 · see citing works
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
Zeltz, C., Pasko, E., Cox, T. R., Navab, R., & Tsao, M. (2019) · Cancers · doi:10.3390/cancers11050705 · Cited by 72 · see citing works
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
Huang, Y., Liang, C.-Y., Ritz, D., Coelho, R., Septiadi, D., Estermann, M., Cumin, C., Rimmer, N., Schötzau, A., López, M. N., et al. (2020) · eLife · doi:10.7554/elife.59442 · Cited by 69 · see citing works
Yamauchi, M., Gibbons, D. L., Zong, C. C., Fradette, J. J., Bota‐Rabassedas, N., & Kurie, J. M. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.001 · Cited by 66 · see citing works
Zhong, C., Tao, B., Tang, F., Yang, X., Peng, T., You, J., Xia, K., Xia, X., Chen, L., & Peng, L. (2020) · Theranostics · doi:10.7150/thno.50613 · Cited by 64 · see citing works
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer
Wang, W., Wang, X., Yao, F., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012270 · Cited by 63 · see citing works
Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
Yang, N., Cao, D., Yin, X., Zhou, H., & Mao, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110791 · Cited by 61 · see citing works
Liang, Y., Xia, W., Zhang, T., Chen, B., Wang, H., Song, X., Zhang, Z., Xu, L., Dong, G., & Jiang, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573534 · Cited by 56 · see citing works
Wang, X., Che, X., Yu, Y., Cheng, Y., Bai, M., Yang, Z., Guo, Q., Xie, X., Li, D., Guo, M., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01703-x · Cited by 55 · see citing works
Chai, C., Liang, L., Mikkelsen, N. S., Wang, W., Zhao, W., Sun, C., Bak, R. O., Li, H., Lin, L., Wang, F., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05826-1 · Cited by 54 · see citing works
Yang, Y., Wang, Y., Ahn, J., Kim, B., & Choi, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113474 · Cited by 52 · see citing works
Li, H., Zeng, C., Shu, C., Cao, Y., Shao, W.-G., Zhang, M., Cao, H., & Zhao, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05472-7 · Cited by 50 · see citing works
Bajwa, P., Kordylewicz, K., Bilecz, A. J., Lastra, R. R., Wroblewski, K., Rinkevich, Y., Lengyel, E. R., & Kenny, H. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163019 · Cited by 49 · see citing works
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
Wang, X., Du, Z., Xu, T., Wang, X., Li, W., Gao, J., Li, J., & Zhu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.785111 · Cited by 46 · see citing works
Kaemmerer, E., Loessner, D., & Avery, V. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.030 · Cited by 46 · see citing works
Brown, Y., Hua, S., & Tanwar, P. S. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.02.004 · Cited by 47 · see citing works
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
Tadić, V., Zhang, W., & Brozović, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189052 · Cited by 43 · see citing works
Expression of LOX Suggests Poor Prognosis in Gastric Cancer
Zhu, J., Luo, C. H., Zhao, J., Zhu, X., Kang, L., Bu, F., Yu, Z., Zou, F., & Zhu, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.718986 · Cited by 40 · see citing works
Uno, K., Iyoshi, S., Yoshihara, M., Kitami, K., Mogi, K., Fujimoto, H., Sugiyama, M., Koya, Y., Yamakita, Y., Nawa, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084383 · Cited by 36 · see citing works
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
Wang, Y., Zhu, N., Liu, J., Chen, F., Song, Y., Ma, Y., Yang, Z., & Wang, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06508-0 · Cited by 41 · see citing works
Shaikat, A. H., Azad, S. M. A. K., Tamim, M. A. R., Ullah, M. S., Amin, M. N., Sabbir, M. K., Tarun, M. T. I., Mostaq, M. S., Sabrin, S., Mahmud, M. Z., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.07.003 · Cited by 37 · see citing works
Giamougiannis, P., Morais, C. L. M., Grabowska, R., Ashton, K. M., Wood, N. J., Martin‐Hirsch, P. L., & Martin, F. L. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-03045-1 · Cited by 33 · see citing works
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 36 · see citing works
Fujimoto, H., Yoshihara, M., Rodgers, R. J., Iyoshi, S., Mogi, K., Miyamoto, E., Hayakawa, S., Hayashi, M., Nomura, S., Kitami, K., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10169-8 · Cited by 29 · see citing works
The prognostic value of the lysyl oxidase family in ovarian cancer
Ye, M., Zhou, J., Gao, Y., Pan, S., & Zhu, X. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23538 · Cited by 30 · see citing works
Han, L., Xu, S., Zhou, D., Chen, R., Ding, Y., Zhang, M., Bao, M., He, B., & Li, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401648 · Cited by 29 · see citing works
Lian, X., Zhang, H., Liu, Q., Lu, X. M., Zhou, P., He, S., Tang, R., & Cui, J. (2020) · 癌症：英文版 · doi:10.1002/cac2.12034 · Cited by 28 · see citing works
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
Hilliard, T. S., Kowalski, B., Iwamoto, K., Agadi, E., Liu, Y., Yang, J., Asem, M., Klymenko, Y., Johnson, J. J., Shi, Z., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212443 · Cited by 27 · see citing works
García‐Olmo, D., Villarejo‐Campos, P., Barambio, J., Gómez‐Heras, S. G., Vega-Clemente, L., López, S. O., Guadalajara, H., & García‐Arranz, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79721-0 · Cited by 26 · see citing works
Schab, A. M., Greenwade, M. M., Stock, E. C., Lomonosova, E., Cho, K., Grither, W. R., Noia, H. M., Wilke, D., Mullen, M. M., Hagemann, A. R., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0347 · Cited by 26 · see citing works
Self-citationThe role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Zheng, A., Wei, Y., Zhao, Y., Zhang, T., & Ma, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013506 · Cited by 25 · see citing works
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 24 · see citing works
Kanniyappan, H., Rathnayake, R. A. C., Osamor, J., Islam, M., & Wang, R. R. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1679625 · Cited by 22 · see citing works
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 25 · see citing works
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?
Mendes, A. D., Freitas, A. R., Vicente, R. S., Vitorino, M. M., Batista, M. V., Silva, M., & Braga, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316589 · Cited by 24 · see citing works
Waters, J. A., Robinson, M., Lujano-Olazaba, O., Lucht, C., Gilbert, S. F., & House, C. D. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2613 · Cited by 20 · see citing works
Zhang, Q., Wu, L., Liu, S., Chen, Q., Zeng, L., Chen, X., & Zhang, Q. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac07d1 · Cited by 19 · see citing works
Bileck, A., Bortel, P., Kriz, M., Janker, L., Kiss, E., Gerner, C., & Favero, G. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.746411 · Cited by 19 · see citing works
The intriguing role of collagen on the rheology of cancer cell spheroids
Tsvirkun, D., Révilloud, J., Giannetti, A., & Claude Verdier, A. (2022) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2022.111229 · Cited by 16 · see citing works
Tumor-initiating cells establish a niche to overcome isolation stress
Wu, C., Weis, S. M., & Cheresh, D. A. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.08.001 · Cited by 14 · see citing works
Improving targeted small molecule drugs to overcome chemotherapy resistance
Rismanbaf, A. (2023) · Cancer Reports · doi:10.1002/cnr2.1945 · Cited by 13 · see citing works
The role of the LOX family in cancer
Boaru, D. L., León-Oliva, D. D., Fraile‐Μartinez, O., Castro-Martinez, P. D., Montero, C. G., Ferrara-Coppola, C., Alhaddadin, M. N. M., Barrena-Blázquez, S., Peñas-González, C. D. L., Holgado-Tirado, N., et al. (2025) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2025.151527 · Cited by 12 · see citing works
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
Clemente-González, C., & Carnero, A. (2022) · Cancers · doi:10.3390/cancers14235930 · Cited by 12 · see citing works
Ma, J., To, S. K. Y., Fung, K. S. W., Wang, K., Zhang, J., Ngan, A. H. W., Yung, S., Chan, T. M., Wong, C. C., Ip, P. P. C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115096 · Cited by 12 · see citing works
Valmiki, S., Aid, M., Chaitou, A. R., Zahid, M., Valmiki, M., Fawzy, P., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.13864 · Cited by 12 · see citing works
Rio, D. D., Masi, I., Caprara, V., Spadaro, F., Ottavi, F., Strippoli, R., Sandoval, P., López‐Cabrera, M., de la Cuesta, R. S., Bagnato, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764375 · Cited by 12 · see citing works
Wang, B., Shan, C., & Guo, B. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24165 · Cited by 11 · see citing works
Liang, R., Yung, M. M. H., He, F., Jiao, P., Chan, K. K. L., Ngan, H., & Chan, D. W. (2021) · Cancers · doi:10.3390/cancers13184577 · Cited by 11 · see citing works
Akanda, M. R., Lubaba, U., Rahman, M. K., Islam, A., Akter, M., Islam, M. S., Uddin, M. N., & Park, B. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155918 · Cited by 10 · see citing works
Ostrowska-Leśko, M., Rajtak, A., Moreno‐Bueno, G., & Bobiński, M. S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189036 · Cited by 10 · see citing works
Launonen, I.-M. P., Vähärautio, A., & Färkkilä, A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041314 · Cited by 10 · see citing works
Nagashima, J. B., Zenilman, S. S., Raab, A., Aranda‐Espinoza, H., & Songsasen, N. (2023) · Bioengineering · doi:10.3390/bioengineering10111285 · Cited by 9 · see citing works
Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer
Gonda, A., Zhao, N., Shah, J. V., Siebert, J. N., Gunda, S., Inan, B., Kwon, M., Libutti, S. K., Moghe, P. V., Francis, N. L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718408 · Cited by 9 · see citing works
Application Of Adoptive Immunotherapy In Ovarian Cancer
Yang, S., Yin, X., Yue, Y., & Wang, S. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s221773 · Cited by 9 · see citing works
Bochner, F., Fellus-Alyagor, L., Ketter, D., Golani, O., Biton, I. E., & Neeman, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0878-7 · Cited by 9 · see citing works
Collagen synthesis and gap junctions: the highway for metastasis of ovarian cancer
Lyu, Y., & Feng, C. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00546-0 · Cited by 8 · see citing works
Tissue Rigidity Increased during Carcinogenesis of NTCU-Induced Lung Squamous Cell Carcinoma In Vivo
Zakaria, M. A., Aziz, J., Rajab, N. F., Chua, E. W., & Masre, S. F. (2022) · Biomedicines · doi:10.3390/biomedicines10102382 · Cited by 7 · see citing works
Zhang, S. (2022) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2022.263 · Cited by 7 · see citing works
The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
Laasik, M., Hynninen, J., Forsback, S. J., Noponen, T., Seppänen, M., & Hietanen, S. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00689-z · Cited by 6 · see citing works
Lama-Sherpa, T. D., Das, S., Hinshaw, D. C., Kammerud, S. C., Song, P. N., Alsheikh, H. A., Sorace, A. G., Samant, R. S., & Shevde, L. A. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0257 · Cited by 6 · see citing works
Grillo, E., Ravelli, C., Corsini, M., Domenichini, M., Scamozzi, M., Zizioli, D., Capoferri, D., Bresciani, R., Romani, C., & Mitola, S. M. F. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151459 · Cited by 5 · see citing works
Kumari, S., Patro, A. R. K., Mishra, B., Jena, S. K., & Singh, S. (2021) · Diagnostics · doi:10.3390/diagnostics12010053 · Cited by 5 · see citing works
Fisher, M., Duhon, B. H., Nguyen, H. T. N., Tonniges, J. R., Wu, K. C., & Ren, Y. (2024) · Otolaryngology · doi:10.1002/ohn.1018 · Cited by 4 · see citing works
Uno, K., Yoshihara, M., Yamakita, Y., Kitami, K., Iyoshi, S., Sugiyama, M., Koya, Y., Kanayama, T., Sahara, H., Nomura, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adu5944 · Cited by 4 · see citing works
Hart, P. C., Bajwa, P., & Kenny, H. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73359-9_5 · Cited by 3 · see citing works
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Chaudhary, B., Kumar, P., Arya, P., Singla, D., Kumar, V., Kumar, D., Roshan, S., Wadhwa, S., Gulati, M., Singh, S. K., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666230110145513 · Cited by 4 · see citing works
Wang, J., Chen, Z., Zhao, P., Wang, Y., Chen, J., & Lin, Q. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03077-0 · Cited by 4 · see citing works
Gonzalez‐Molina, J., Nabili, P., Marciano, D., Abdelnabi, S., Gultekin, O., Rasul, M. F., Zhang, Y., Nadal, C., Chrysanthou, A., Alkasalias, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62296-7 · Cited by 3 · see citing works
Hua, M., Chen, Y., Jia, M., Lv, W., Xu, Y., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33201 · Cited by 3 · see citing works
Han, X., Caron, J. M., Lary, C. W., Sathyanarayana, P., Vary, C., & Brooks, P. C. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.009 · Cited by 3 · see citing works
Expression of Amine Oxidase Proteins in Adrenal Cortical Neoplasm and Pheochromocytoma
Kim, E. K., & Koo, J. S. (2023) · Biomedicines · doi:10.3390/biomedicines11071896 · Cited by 3 · see citing works
Krawiec, A., Pietrasik, J., Pietrasik, Z., Mikuła‐Pietrasik, J., & Książek, K. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111843 · Cited by 3 · see citing works
García‐Arranz, M., Villarejo‐Campos, P., Barambio, J., Gómez‐Heras, S. G., Vega-Clemente, L., Guadalajara, H., & García‐Olmo, D. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02524-2 · Cited by 3 · see citing works
Qi, Y., Zhang, W., Li, X., Shi, Y., & Qu, P. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101740 · Cited by 2 · see citing works
Natarajan, S., Nguyen, K. D. P., Li, H., Saputra, E. C., Li, C., Kim, G., Liu, Y., Sun, H., Ramli, M. N., Li, L., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-1121 · Cited by 2 · see citing works
Self-citationSurti, M., Gupta, A., Janiyani, K., Adnan, M., & Patel, M. B. (2026) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2026.01.009 · Cited by 2 · see citing works
Malacrida, B., Elorbany, S., Laforêts, F., Karim, F., Bryan-Ravenscroft, R. C., Sideris, M. C., Joy, J. D., Kotantaki, P., Skingsley, S. L. P., Heath, O. M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70398-z · Cited by 2 · see citing works
Expression of amine oxidase-related proteins in breast phyllodes tumor.
Kim, H. M., & Koo, J. S. (2025) · PubMed · doi:10.14670/hh-18-773 · Cited by 2 · see citing works
Wei, W., Zhang, Y., Li, Y., Huang, J., Kang, F., Tan, S., Lin, L., Lu, X., Wei, H., & Wang, N. (2025) · International Journal of Cancer · doi:10.1002/ijc.35387 · Cited by 2 · see citing works
Models of High-Grade Serous Ovarian CarcinomaPreprint
Pundel, O. J., & Neel, B. G. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041949 · Cited by 2 · see citing works
Wei, G., Zhu, X., Chen, X. S., Lv, J., Xiang, F., Zhang, M., Tao, K. X., Wen, W., He, D., Wu, X., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2700024 · Cited by 1 · see citing works
Tumor Microenvironment Complexity: A Pathological Milieu that Innately Modulates Cancer Progression
Balahura, L.-R., Lazăr, A. D., Dinescu, S., & Costache, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_89-1 · Cited by 2 · see citing works
Non-Invasive and Real-Time Monitoring of the Breast Cancer Metastasis Degree via Metabolomics
Zhu, W., Qian, W., Liao, W., Huang, X., Xu, J., Qu, W., Xue, J., Feng, F., Liu, W., Liu, F., et al. (2022) · Cancers · doi:10.3390/cancers14225589 · Cited by 1 · see citing works
- Authors
- Natarajan, S., Foreman, K. M., Soriano, M. I., Rossen, N. S., Shehade, H., Fregoso, D. R., Eggold, J. T., Krishnan, V., Dorigo, O., Krieg, A. J., Heilshorn, S. C., Sinha, S., Fuh, K. C., & Rankin, E. B.
- Affiliations
- Stanford University (US)
- Oregon Health & Science University (US)
- SRI International (US)
- Washington University in St. Louis (US)
- Corresponding author
- Rankin, Erinn B.
- ORCID
- Venue
- Cancer Research
- Published
- 2019-05-01
- Volume
- 79
- Issue
- 9
- Pages
- 2271-2284
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC6822898
- OpenAlex
- W2921266140
- Cited by
- 129
- References
- 54
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 15 · 2023: 18 · 2022: 20 · 2021: 20 · 2020: 24 · 2019: 3
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Defense for Health Affairs (W81XWH-15-1-0097)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- high-grade serous ovarian cancer, peritoneal carcinomatosis, mesothelial cells, hypoxia, collagen remodeling, collagen I deposition, lysyl oxidase, collagen cross-linking, extracellular matrix, tumor invasion, HIF signaling, omental metastases, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adult, Aged, Aged, 80 and over, Animals, Hypoxia, Collagen, Epithelium, Extracellular Matrix, Female, Humans, Protein-Lysine 6-Oxidase, Middle Aged, Ovarian Neoplasms, Peritoneal Neoplasms, Prognosis, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice, SCID, Mice, Inbred NOD, Apoptosis, Cystadenocarcinoma, Serous, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
